Jane E. Onken

4.1k total citations · 1 hit paper
41 papers, 2.8k citations indexed

About

Jane E. Onken is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Jane E. Onken has authored 41 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Genetics and 9 papers in Surgery. Recurrent topics in Jane E. Onken's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (9 papers) and Colorectal Cancer Screening and Detection (6 papers). Jane E. Onken is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (9 papers) and Colorectal Cancer Screening and Detection (6 papers). Jane E. Onken collaborates with scholars based in United States, Canada and United Kingdom. Jane E. Onken's co-authors include Bruce E. Sands, Brian G. Feagan, Michael A. Kamm, Paul Rutgeerts, William Y. Chey, Joshua R. Korzenik, P Marsters, Daniel Rachmilewitz, Çharles N. Bernstein and Marion Blank and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Jane E. Onken

38 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

2004 1.6k citations Bruce E. Sands, Frank Anderson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane E. Onken United States	20	1.6k	1.2k	900	457	344	41	2.8k
Donald MacIntosh Canada	15	2.2k 1.4×	1.9k 1.5×	818 0.9×	677 1.5×	254 0.7×	33	2.9k
Nicolas Williet France	22	1.3k 0.8×	1.1k 0.9×	585 0.7×	345 0.8×	249 0.7×	70	2.2k
Mark T. Osterman United States	31	2.1k 1.3×	1.7k 1.4×	781 0.9×	707 1.5×	245 0.7×	157	3.2k
Jean Yves Mary France	13	1.4k 0.8×	1.2k 0.9×	583 0.6×	525 1.1×	384 1.1×	26	2.6k
Ambrogio Orlando Italy	31	2.5k 1.5×	2.7k 2.2×	1.2k 1.3×	591 1.3×	159 0.5×	152	4.5k
A. Cassinotti Italy	24	1.2k 0.7×	987 0.8×	497 0.6×	394 0.9×	118 0.3×	59	2.0k
William Connell Australia	23	1.5k 0.9×	1.1k 0.9×	745 0.8×	218 0.5×	106 0.3×	66	2.5k
Michael Safdi United States	25	2.0k 1.2×	1.5k 1.3×	1.3k 1.5×	599 1.3×	229 0.7×	45	3.8k
Fernando Velayos United States	29	2.5k 1.5×	1.9k 1.6×	1.1k 1.2×	566 1.2×	84 0.2×	92	3.8k
P Prior United Kingdom	27	1.5k 0.9×	2.2k 1.8×	1.5k 1.7×	295 0.6×	167 0.5×	41	4.8k

Countries citing papers authored by Jane E. Onken

Since Specialization

Citations

This map shows the geographic impact of Jane E. Onken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Onken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Onken more than expected).

Fields of papers citing papers by Jane E. Onken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Onken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Onken. The network helps show where Jane E. Onken may publish in the future.

Co-authorship network of co-authors of Jane E. Onken

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Onken. A scholar is included among the top collaborators of Jane E. Onken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Onken. Jane E. Onken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pawlak, Katarzyna M., Samir C. Grover, Joost P.H. Drenth, Jane E. Onken, & Keith Siau. (2022). How to Train the Next Generation to Provide High-Quality Peer-Reviews. Clinical Gastroenterology and Hepatology. 20(9). 1902–1906.

Lichtenstein, Gary R. & Jane E. Onken. (2018). Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron. Digestive Diseases and Sciences. 63(11). 3009–3019. 14 indexed citations

Rose, Suzanne, et al.. (2015). Introducing the Gastroenterologist-accountable Professionalism in Practice (G-APP) Pathway: Bridging the G-APP-Replacing MOC With a Model for Lifelong Learning and Accountability. Clinical Gastroenterology and Hepatology. 13(11). 1872–1892.

Roe, Matthew T., Derek D. Cyr, Phillip J. Schulte, et al.. (2015). Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. European Heart Journal. 37(4). ehv611–ehv611. 20 indexed citations

Onken, Jane E., David B. Bregman, Robert A. Harrington, et al.. (2013). A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 54(2). 306–315. 125 indexed citations

Onken, Jane E., David B. Bregman, Robert A. Harrington, et al.. (2013). Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrology Dialysis Transplantation. 29(4). 833–842. 95 indexed citations

Onken, Jane E.. (2008). Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?. Inflammatory Bowel Diseases. 14. S196–S197. 1 indexed citations

Hampton, Daniel, Martin Poleski, & Jane E. Onken. (2008). Inflammatory bowel disease following solid organ transplantation. Clinical Immunology. 128(3). 287–293. 45 indexed citations

Micames, Carlos G., Rex C. Bentley, & Jane E. Onken. (2007). Clinical Challenges and Images in GI. Gastroenterology. 133(2). 391–731. 2 indexed citations

10.

Onken, Jane E., Paula K. Greer, Brian Calingaert, & Laura P. Hale. (2007). Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clinical Immunology. 126(3). 345–352. 85 indexed citations

11.

Arseneau, Kristen O., Shahnaz Sultan, Dawn Provenzale, et al.. (2006). Do Patient Preferences Influence Decisions on Treatment for Patients With Steroid-Refractory Ulcerative Colitis?. Clinical Gastroenterology and Hepatology. 4(9). 1135–1142. 53 indexed citations

12.

Provenzale, Dawn & Jane E. Onken. (2005). Tpmt Genotype Screening for Patients About to Begin Azathioprine Treatment-a Look at Costs and Potential Benefits. Inflammatory Bowel Diseases. 11(12). 1119–1120. 3 indexed citations

13.

Sands, Bruce E., Frank Anderson, Çharles N. Bernstein, et al.. (2004). Infliximab Maintenance Therapy for Fistulizing Crohn's Disease. New England Journal of Medicine. 350(9). 876–885. 1607 indexed citations breakdown →

14.

Sands, Bruce E., Carmen Cuffari, Jeffry Katz, et al.. (2004). Guidelines for Immunizations in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 10(5). 677–692. 181 indexed citations

15.

Onken, Jane E., Joëlle Y. Friedman, Sujha Subramanian, et al.. (2002). Treatment patterns and costs associated with sessile colorectal polyps. The American Journal of Gastroenterology. 97(11). 2896–2901. 41 indexed citations

16.

Bloomfeld, Richard S. & Jane E. Onken. (2002). Mercaptopurine metabolite results in clinical gastroenterology practice. Alimentary Pharmacology & Therapeutics. 17(1). 69–73. 33 indexed citations

17.

Provenzale, Dawn & Jane E. Onken. (2001). Surveillance Issues in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 32(2). 99–105. 40 indexed citations

18.

Provenzale, Dawn, John B. Wong, Jane E. Onken, & Joseph Lipscomb. (1998). Performing a Cost-Effectiveness Analysis: Surveillance of Patients With Ulcerative Colitis. The American Journal of Gastroenterology. 93(6). 872–880. 43 indexed citations

19.

Cotton, P B, et al.. (1997). ERCP and sphincterotomy in the context of laparoscopic cholecystectomy: academic and community practice patterns and results.. PubMed. 92(4). 597–601. 36 indexed citations

20.

Brazer, Scott R., Jane E. Onken, Christine B. Dalton, Judy Smith, & Susan S. Schiffman. (1995). Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiology & Behavior. 57(3). 563–567. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact